Venmax Drugs & Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 531015 Small Cap ISIN: INE154G01022

As on 22 June 2026 at 22:12 IST

₹20.90

+ 0.95

(4.76%)

Sell Buy

Over 1 Month

-13.34%

Over 6 Months

-25.39%

Over 1 Year

-25.34%

Over 3 Years

None%

Venmax Drugs & Pharmaceuticals Ltd Summary

Close ₹19.95

Open ₹20

High ₹21.40

Low ₹19.95

Volume 890

Net Turnover (in Cr) ₹0.0017

52Wk High ₹36.96

52Wk Low ₹19.01

52Wk High / Low

19.01

36.96

Venmax Drugs & Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹23.11

EPS (TTM) 0.21

Book Value (BV) 12.18

Div. Yield -

P/E (TTM) 95

Price/Book Value 1.64

Delivery % 98.54 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -22.63

EV to Sales 15.44

PEG Ratio -

ROA -0.22

ROE -

Debt-Equity 0.11

Net Profit Margin 14.81

Operating Profit Margin 14.81

Venmax Drugs & Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1.86	0.20	0.42	1.98	0.35
Total Expenses	1.87	0.11	0.19	0.14	0.51
Profit Before Tax	-0.01	0.09	0.23	1.85	-0.16
Profit After Tax	-0.01	0.06	0.23	1.85	-0.16
Operating Profit After Depreciation	-0.01	0.09	0.23	1.85	-0.16

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.04	0.07	0.07	0.08	0.09
Total Non Current Assets	0.04	0.07	0.07	0.08	0.09
Total Current Assets	5.13	0.02	0.14	0.13	0.22
Total Assets	5.17	0.08	0.21	0.21	0.31
Total Shareholder's Fund	4.41	-0.65	-0.71	-0.94	-2.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-2.29	-	-	1.91	0.26
Net Cash Used In Investing Activities	-	-	-	-	-
Net Cash Used In Financing Activities	4.77	-	-	-1.98	-0.19

No data available

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	3.94	1.55	1.32	1.21	0.33
Total Expenses	3.93	1.58	1.27	1.17	0.58
Profit Before Tax	0.10	0.04	0.05	0.04	0.77
Profit After Tax	0.11	0.03	0.02	0.04	0.78
Operating Profit after Depreciation	0.10	0.04	0.05	0.04	0.77

Venmax Drugs & Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 19.47

S2 18.98

S3 18.02

Pivot 20.43

R1 20.92

R2 21.88

R3 22.37

Moving Average

20 SMA 22.71

50 SMA 24.21

100 SMA 24.89

200 SMA 25.93

Venmax Drugs & Pharmaceuticals Ltd Corporate Actions

No available data

Venmax Drugs & Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Venmax Drugs & Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Venmax Drugs & Pharmaceuticals Ltd News

Venmax Drugs & Pharmaceuticals to announce Quarterly Result

On 14 May 2026

07 May 2026, 11:20 am

Venmax Drugs & Pharmaceuticals announces board meeting date

On 7 February 2026

31 Jan 2026, 09:50 am

Venmax Drugs & Pharmaceuticals to discuss results

On 12 November 2025

06 Nov 2025, 12:34 pm

Venmax Drugs & Pharmaceuticals to convene AGM

On 27 September 2025

09 Sep 2025, 05:54 pm

Venmax Drugs & Pharmaceuticals schedules board meeting

On 2 September 2025

25 Aug 2025, 05:37 pm

Venmax Drugs & Pharmaceuticals Ltd Stock Analysis

Annual revenue for Venmax Drugs & Pharmaceuticals Ltd increased by 836.81% to ₹1.86 crore in FY 2025 from ₹0.20 crore in FY 2024.
Annual Net Profit for Venmax Drugs & Pharmaceuticals Ltd decreased by 116.28% to ₹-0.01 crore in FY 2025 from ₹0.06 crore in FY 2024.
Promoter Shareholding in Venmax Drugs & Pharmaceuticals Ltd decreased by 8.82% in the most recent quarter, from 15.14% in December 2025 to 13.80% in March 2026.
Venmax Drugs & Pharmaceuticals Ltd delivered a 1-year return of -25.34% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Venmax Drugs & Pharmaceuticals Ltd share price moved up by 4.76% from its previous close of INR ₹19.95. The latest Venmax Drugs & Pharmaceuticals Ltd share price is INR ₹20.90.
Venmax Drugs & Pharmaceuticals Ltd share price today has been at a low of 20.35 and a high of 20.90. Over the past 52 weeks, the Venmax Drugs & Pharmaceuticals Ltd share price has seen a low of 19.01 and a high of 36.96.